These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29330543)

  • 61. DMD and West syndrome.
    Cardas R; Iliescu C; Butoianu N; Seferian A; Gataullina S; Gargaun E; Nectoux J; Bienvenu T; Craiu D; Gidaro T; Servais L
    Neuromuscul Disord; 2017 Oct; 27(10):911-913. PubMed ID: 28802771
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Prenatal diagnosis and carriers in families with Duchenne muscular dystrophy. The introduction of new markers].
    Montejo-Pujadas Y; Zaldívar-Vaillant T; Acevedo-López AM; Guerra-Badía R
    Rev Neurol; 2001 Dec 1-15; 33(11):1094-5. PubMed ID: 11785038
    [No Abstract]   [Full Text] [Related]  

  • 63. Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements.
    D'Amico A; Catteruccia M; Baranello G; Politano L; Govoni A; Previtali SC; Pane M; D'Angelo MG; Bruno C; Messina S; Ricci F; Pegoraro E; Pini A; Berardinelli A; Gorni K; Battini R; Vita G; Trucco F; Scutifero M; Petillo R; D'Ambrosio P; Ardissone A; Pasanisi B; Vita G; Mongini T; Moggio M; Comi GP; Mercuri E; Bertini E
    Neuromuscul Disord; 2017 May; 27(5):447-451. PubMed ID: 28262469
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preserving function in Duchenne dystrophy with long-term pulse prednisone therapy.
    Carter GT; McDonald CM
    Am J Phys Med Rehabil; 2000; 79(5):455-8. PubMed ID: 10994887
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy.
    Ross LF
    Am J Med Genet A; 2006 Apr; 140(8):914-22. PubMed ID: 16528755
    [TBL] [Abstract][Full Text] [Related]  

  • 66. EMG-based Indicators of Muscular Co-Activation during Gait in Children with Duchenne Muscular Dystrophy.
    Rinaldi M; Petrarca M; Romano A; Vasco G; D'Anna C; Schmid M; Castelli E; Conforto S
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():3845-3848. PubMed ID: 31946712
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Three-tiered noninvasive diagnosis in 96% of patients with Duchenne muscular dystrophy (DMD).
    Yan J; Feng J; Buzin CH; Scaringe W; Liu Q; Mendell JR; Dunnen JD; Sommer SS
    Hum Mutat; 2004 Feb; 23(2):203-204. PubMed ID: 14722924
    [No Abstract]   [Full Text] [Related]  

  • 68. Symptomatic therapy of Duchenne muscular dystrophy (DMD).
    Rüdel R
    Acta Myol; 2012 May; 31(1):2-3. PubMed ID: 22655509
    [No Abstract]   [Full Text] [Related]  

  • 69. Newborn screening for Duchenne muscular dystrophy gains support: researchers to push for federal recommendation to have states add DMD test to newborn panel.
    Levenson D
    Am J Med Genet A; 2012 Dec; 158A(12):viii-ix. PubMed ID: 23174945
    [No Abstract]   [Full Text] [Related]  

  • 70. Genetic counseling for childless women at risk for Duchenne muscular dystrophy.
    Eggers S; Pavanello RC; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1999 Oct; 86(5):447-53. PubMed ID: 10508987
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An Opportune Time for Newborn Screening in Duchenne Muscular Dystrophy.
    Chrzanowski SM; McAnally MM; Kang PB
    JAMA Neurol; 2021 Aug; 78(8):901-902. PubMed ID: 34152378
    [No Abstract]   [Full Text] [Related]  

  • 72. Duchenne muscular dystrophy.
    Biggar WD
    Pediatr Rev; 2006 Mar; 27(3):83-8. PubMed ID: 16510548
    [No Abstract]   [Full Text] [Related]  

  • 73. Looking under every rock: Duchenne muscular dystrophy and traditional Chinese medicine.
    Urtizberea JA; Fan QS; Vroom E; Récan D; Kaplan JC
    Neuromuscul Disord; 2003 Nov; 13(9):705-7. PubMed ID: 14561492
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Newborn screening for Duchenne muscular dystrophy.
    Parsons EP; Bradley DM; Clarke AJ
    Arch Dis Child; 2003 Jan; 88(1):91-2. PubMed ID: 12495984
    [No Abstract]   [Full Text] [Related]  

  • 75. Muscular dystrophy.
    Roland EH
    Pediatr Rev; 2000 Jul; 21(7):233-7; quiz 238. PubMed ID: 10878185
    [No Abstract]   [Full Text] [Related]  

  • 76. Beware the laboratory report: discrepancy in variant classification on reproductive carrier screening.
    Ramdaney A; Dunn DM; Weiss RB; Rose NC
    Genet Med; 2018 Mar; 20(3):374-375. PubMed ID: 29261181
    [No Abstract]   [Full Text] [Related]  

  • 77. Can urinary titin be used for predicting Duchenne muscular dystrophy?
    Bai SM; Guo XX
    Clin Chim Acta; 2019 Mar; 490():161. PubMed ID: 30391395
    [No Abstract]   [Full Text] [Related]  

  • 78. Evaluation of microchip electrophoresis as a molecular diagnostic method for Duchenne muscular dystrophy.
    Ferrance J; Snow K; Landers JP
    Clin Chem; 2002 Feb; 48(2):380-3. PubMed ID: 11805028
    [No Abstract]   [Full Text] [Related]  

  • 79. 195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands.
    Ellis JA; Vroom E; Muntoni F
    Neuromuscul Disord; 2013 Aug; 23(8):682-9. PubMed ID: 23791627
    [No Abstract]   [Full Text] [Related]  

  • 80. Muscular dystrophies.
    Wong BL
    Pediatr Ann; 2005 Jul; 34(7):507-10. PubMed ID: 16092623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.